FBIOP
Price
$9.47
Change
+$0.72 (+8.23%)
Updated
Jun 6 closing price
Capitalization
N/A
INDP
Price
$0.34
Change
-$0.01 (-2.86%)
Updated
Jun 6 closing price
Capitalization
5.56M
70 days until earnings call
Interact to see
Advertisement

FBIOP vs INDP

Header iconFBIOP vs INDP Comparison
Open Charts FBIOP vs INDPBanner chart's image
Fortress Biotech
Price$9.47
Change+$0.72 (+8.23%)
Volume$23.9K
CapitalizationN/A
Indaptus Therapeutics
Price$0.34
Change-$0.01 (-2.86%)
Volume$142.15K
Capitalization5.56M
FBIOP vs INDP Comparison Chart
Loading...
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FBIOP vs. INDP commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Buy and INDP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (FBIOP: $6.75 vs. INDP: $0.32)
Brand notoriety: FBIOP and INDP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 195% vs. INDP: 406%
Market capitalization -- FBIOP: $0 vs. INDP: $5.56M
FBIOP [@Biotechnology] is valued at $0. INDP’s [@Biotechnology] market capitalization is $5.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green whileINDP’s FA Score has 1 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • INDP’s FA Score: 1 green, 4 red.
According to our system of comparison, FBIOP is a better buy in the long-term than INDP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 5 TA indicator(s) are bullish while INDP’s TA Score has 4 bullish TA indicator(s).

  • FBIOP’s TA Score: 5 bullish, 3 bearish.
  • INDP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FBIOP is a better buy in the short-term than INDP.

Price Growth

FBIOP (@Biotechnology) experienced а +1.40% price change this week, while INDP (@Biotechnology) price change was -16.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

INDP is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FBIOP YTD gains are higher at: 1.549 vs. INDP (-62.214). INDP has higher annual earnings (EBITDA): -15.37M vs. FBIOP (-108.52M). FBIOP has more cash in the bank: 58.9M vs. INDP (5.79M). INDP has less debt than FBIOP: INDP (84.2K) vs FBIOP (71.5M). FBIOP has higher revenues than INDP: FBIOP (62.5M) vs INDP (0).
FBIOPINDPFBIOP / INDP
CapitalizationN/A5.56M-
EBITDA-108.52M-15.37M706%
Gain YTD1.549-62.214-2%
P/E RatioN/AN/A-
Revenue62.5M0-
Total Cash58.9M5.79M1,018%
Total Debt71.5M84.2K84,917%
FUNDAMENTALS RATINGS
FBIOP vs INDP: Fundamental Ratings
FBIOP
INDP
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
28
Undervalued
PROFIT vs RISK RATING
1..100
10098
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
5397
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIOP's Valuation (1) in the null industry is in the same range as INDP (28). This means that FBIOP’s stock grew similarly to INDP’s over the last 12 months.

INDP's Profit vs Risk Rating (98) in the null industry is in the same range as FBIOP (100). This means that INDP’s stock grew similarly to FBIOP’s over the last 12 months.

INDP's SMR Rating (99) in the null industry is in the same range as FBIOP (100). This means that INDP’s stock grew similarly to FBIOP’s over the last 12 months.

FBIOP's Price Growth Rating (53) in the null industry is somewhat better than the same rating for INDP (97). This means that FBIOP’s stock grew somewhat faster than INDP’s over the last 12 months.

FBIOP's P/E Growth Rating (100) in the null industry is in the same range as INDP (100). This means that FBIOP’s stock grew similarly to INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPINDP
RSI
ODDS (%)
Bearish Trend 12 days ago
53%
Bullish Trend 12 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
56%
Bullish Trend 12 days ago
89%
Momentum
ODDS (%)
Bullish Trend 12 days ago
59%
Bearish Trend 12 days ago
88%
MACD
ODDS (%)
Bullish Trend 12 days ago
59%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
60%
Bearish Trend 12 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
56%
Bearish Trend 12 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
63%
Bullish Trend 27 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
62%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 12 days ago
74%
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
FBIOP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been closely correlated with HLVX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBIOP jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
-0.56%
HLVX - FBIOP
82%
Closely correlated
-1.61%
FBIO - FBIOP
26%
Poorly correlated
+3.83%
ACXP - FBIOP
10%
Poorly correlated
-1.52%
INDP - FBIOP
8%
Poorly correlated
-1.88%
ELTX - FBIOP
6%
Poorly correlated
+21.87%
More

INDP and

Correlation & Price change

A.I.dvisor tells us that INDP and COYA have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INDP and COYA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-1.88%
COYA - INDP
28%
Poorly correlated
-1.58%
ISCO - INDP
25%
Poorly correlated
+8.11%
NKTR - INDP
24%
Poorly correlated
+3.68%
KALV - INDP
23%
Poorly correlated
+1.60%
NTLA - INDP
23%
Poorly correlated
+3.59%
More